Overview

An expert guide to the entire range of primary and secondary cutaneous lymphomas and pseudolymphomas In the newly revised sixth edition of Skin Lymphoma: The Illustrated Guide, renowned dermatopathologist Dr. Lorenzo Cerroni delivers an up-to-date discussion of the entire spectrum of primary and secondary cutaneous lymphomas and pseudolymphomas of the skin. This edition includes 33 richly illustrated chapters covering primary cutaneous lymphomas, specific cutaneous manifestations of extracutaneous lymphomas and leukemias, the broad spectrum of cutaneous pseudolymphomas, and a wide variety of other clinically and pathologically relevant subjects on the topic. The book offers a large collection of clinical and histopathological figures depicting everything from cutaneous NK/T-cell and B-cell lymphomas and lymphoproliferative disorders to cutaneous atypical lymphoid proliferation. Readers will also find: Comprehensive explorations of cutaneous lymphomas and lymphoproliferative disorders in immune deficient and immune dysregulated patients Detailed coverage of composite lymphomas involving the skin Particular analysis of cutaneous lymphomas in pediatrics Dedicated section on non-neoplastic cutaneous signs of hematological malignancies Complete overview of pseudolymphomas of the skin Perfect for dermatologists, hematologists, general pathologists, dermatopathologists, and hemato-pathologists, Skin Lymphoma: The Illustrated Guide will also benefit medical students and researchers with an interest in pathology, dermatology, and hematology.

Full Product Details

Author:   Lorenzo Cerroni (Medical University of Graz, Austria)
Publisher:   John Wiley & Sons Inc
Imprint:   John Wiley & Sons Inc
Edition:   6th edition
Dimensions:   Width: 22.40cm , Height: 3.80cm , Length: 27.90cm
Weight:   2.223kg
ISBN:  

9781394235483

ISBN 10:   1394235488
Pages:   720
Publication Date:   12 March 2026
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Awaiting stock  
The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you.

Table of Contents

Preface, 1          Introduction, Section 1: Cutaneous NK/T-cell lymphomas and lymphoproliferative disorders 2          The ""parapsoriases"", 3          Mycosis fungoides,                         Adnexotropic mycosis fungoides                         Pustular mycosis fungoides                         Localized pagetoid reticulosis (Woringer–Kolopp type)                         Unilesional (“solitary”) mycosis fungoides                         Granulomatous mycosis fungoides                         Granulomatous slack skin                         Erythrodermic mycosis fungoides                         Mycosis fungoides mimicking eczematous dermatoses                         Interstitial mycosis fungoides                         Poikilodermatous mycosis fungoides (""poikiloderma vasculare atrophicans"")                         Hypopigmented mycosis fungoides                         Hyperpigmented mycosis fungoides                         Purpuric mycosis fungoides                         Papular mycosis fungoides                         Pityriasis lichenoides-like mycosis fungoides                         Bullous (vesiculobullous) and dyshidrotic mycosis fungoides                         Anetodermic mycosis fungoides                         “Invisible” mycosis fungoides                         Psoriasiform mycosis fungoides                         Nevoid hyperkeratosis of the nipple and mycosis fungoides                         Acanthosis nigricans-like mycosis fungoides 4          Sézary syndrome, 5          Primary cutaneous CD30+ lymphoproliferative disorders, Lymphomatoid papulosis, Cutaneous anaplastic large cell lymphoma, “Borderline” cases, Intralymphatic anaplastic large cell lymphoma, Implant–associated anaplastic large cell lymphoma, 6          Subcutaneous panniculitis-like T-cell lymphoma, 7          Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma 8          Primary cutaneous g/d T-cell lymphoma, 9          Cutaneous extranodal NK/T-cell lymphoma, nasal type, 10        Cutaneous peripheral T-cell lymphoma, not otherwise specified (NOS), 11        Cutaneous CD4+ small–medium T-cell lymphoproliferative disorder, 12        Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder, 13        Cutaneous adult T-cell leukemia/lymphoma, 14        Specific cutaneous manifestations of nodal T-follicular helper cell lymphoma, angioimmunoblastic type and of other nodal T-follicular helper cell lymphomas 15        Cutaneous manifestations in Epstein-Barr virus-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood             Severe mosquito bite allergy, Hydroa vacciniforme lymphoproliferative disorder,                         Classic hydroa vacciniforme,                         Systemic hydroa vacciniforme lymphoproliferative disorder Section 2: Cutaneous B-cell lymphomas and lymphoproliferative disorders 16        Cutaneous follicle center lymphoma, 17        Cutaneous marginal zone lymphproliferative disorder and variants, Cutaneous marginal zone lymphproliferative disorder, conventional variant, Cutaneous marginal zone lymphproliferative disorder, lymphoplasmacytic variant, Cutaneous marginal zone lymphproliferative disorder, plasmacytic variant, Cutaneous marginal zone lymphproliferative disorder, blastoid variant, Cutaneous amyloidoma 18        Cutaneous diffuse large B-cell lymphoma, leg type, 19        Intravascular large cell lymphomas, Intravascular large B-cell lymphoma, Intravascular large NK/T-cell lymphoma, 20        Other cutaneous B-cell lymphomas, Specific cutaneous manifestations in Epstein-Barr virus (EBV)+ diffuse large B-cell lymphoma, Specific cutaneous manifestations in mantle cell lymphoma, Specific cutaneous manifestations in extracavitary primary effusion lymphoma, Specific cutaneous manifestations in multiple myeloma, Specific cutaneous manifestations in Burkitt lymphoma, Cutaneous lymphomatoid granulomatosis, Cutaneous plasmablastic lymphoma, Cutaneous T-cell/histiocyte-rich large B-cell lymphoma, Cutaneous manifestations in Waldenström macroglobulinemia, Section 3: Cutaneous lymphomas and lymphoproliferative disorders in the setting of immune deficiency / dysregulation 21        Cutaneous lymphoproliferative disorders and lymphomas in the setting of immune deficiency / dysregulation,                         Posttransplant immunodeficiency / dysregulation,                         Human immunodeficiency virus (HIV)-related immune deficiency / dysregulation,                         Immune deficiency / dysregulation due to other iatrogenic and non-iatrogenic factors,                         Cutaneous plasmacytic hyperplasia associated with immune deficiency / dysregulation,                         Cutaneous polymorphic B-cell lymphoproliferative disorder associated with immune deficiency / dysregulation, Epstein-Barr virus (EBV)-associated mucocutaneous ulcer, Cutaneous manifestations of multicentric Castleman disease, Section 4: Specific cutaneous manifestations of leukemias and of precursor hematologic neoplasms 22        Cutaneous manifestations of B-cell chronic lymphocytic leukemia,                         Progression to diffuse large B-cell lymphoma (Richter syndrome) 23        Cutaneous manifestations of myelogenous leukemia,                         Acute myeloid leukemka                         Chronic myelogeneous leukemia                         Myelodysplastic syndromes (myelodysplastic neoplasms)                         Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasms 24        Blastic plasmacytoid dendritic cell neoplasm, 25        Cutaneous manifestations of other leukemias, T-cell prolymphocytic leukemia, Aggressive natural killer cell leukemia, Specific skin manifestations of other types of leukemia,                         Hairy cell leukemia                         B-cell prolymphocytic leukemia                         T-cell large granular lymphocytic leukemia 26        Cutaneous lymphoblastic lymphomas, Cutaneous B-lymphoblastic lymphoma, Cutaneous T-lymphoblastic lymphoma, Section 5: Cutaneous manifestations of other lymphomas and non-neoplastic cutaneous signs of systemic lymphomas 27        Cutaneous manifestations of Hodgkin lymphoma, 28        Cutaneous composite lymphomas, 29        Non-neoplastic cutaneous signs of systemic lymphomas, Section 6: Cutaneous lymphomas and lymphoproliferative disorders in children and adolescents 30        Cutaneous lymphomas and lymphoproliferative disorders in children and adolescents, Section 7: Pseudolymphomas of the skin 31        Pseudolymphomas of the skin, Chronic actinic dermatitis (actinic reticuloid), Lymphomatoid contact dermatitis, Pseudolymphomatous atopic dermatitis and other eczematous dermatoses, Pseudolymphomatous psoriasis Pseudolymphomatous lichen planus Non-mycosis fungoides-associated follicular mucinosis and other mimickers of pilotropic/adnexotropic mycosis fungoides, Non-neoplastic erythroderma in adult patients, Cutaneous pseudolymphoma associated with mogamulizumab treatment Solitary idiopathic T/B-cell pseudolymphoma, Lichenoid/lymphomatoid)keratosis, Pityriasis lichenoides, Lichen aureus/lichenoid pigmented purpuric dermatitis, Lichen sclerosus, Other pseudolymphomas in genital skin and mucosal regions Vitiligo (inflammatory stage), Annular lichenoid dermatitis of youth, Pseudolymphomatous cutaneous infiltrates in human immunodeficiency virus (HIV)-infected patients and in other immune deficiencies, CD30+ T-cell pseudolymphomas, Persistent nodular arthropod bite reactions and nodular scabies, Milker's nodule and orf Pseudolymphomas in herpes simplex and herpes zoster infections, Pseudolymphomas associated with lupus erythematosus, Lymphomatoid drug reactions, Lymphocytoma cutis, Pseudolymphomas associated with infection by Borrelia species Lymphocytoma cutis associated with Borrelia infection, Pseudolymphomatous acrodermatitis chronica atrophicans, Pseudolymphomas at sites of vaccination, Pseudolymphomas in tattoos, Localized scleroderma/morphea, Cutaneous IgG4-related disease, Pseudolymphomas in syphilis, Cutaneous plasma cell granuloma, Cutaneous and systemic plasmacytosis, Angiomatoid pseudolymphoma (T-cell-rich angiomatoid polypoid pseudolymphoma / Acral pseudolymphomatous angiokeratoma in children / Pre-tibial lymphoplasmacytic plaque in children), Cutaneous extramedullary hematopoiesis, Histiocytoid cells in Sweet syndrome and other conditions, Intralymphatic histiocytosis, Benign intralymphatic proliferation of T-cell lymphoid blasts, Other “accidental” pseudolymphomas, 32        Non lymphoid malignant neoplasms of the skin mimicking histopathologically cutaneous lymphomas (""malignant pseudolymphomas""),             Lymphoepithelial-like carcinoma of the skin             Pseudolymphomatous angiosarcoma             Histiocytic sarcoma             Follicular dendritic cell sarcoma             Cutaneous mastocytosis             Cutaneous Langerhans cell histiocytosis Section 8: The cutaneous “atypical lymphoid proliferation” 33        The cutaneous “atypical lymphoid proliferation”, Index,

Reviews

Author Information

Lorenzo Cerroni is the Director of the Dermatopathology Unit at the Medical University of Graz, Austria. He is the past President of the International Society of Dermatopathology and a recipient of numerous prestigious dermatology and dermatopathology awards.

Tab Content 6

Author Website:  

Countries Available

All regions